Related Experiment Videos
Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review
Matthieu Béreau1, Vanessa Fleury2, Walid Bouthour2
1Service de neurologie, université de Franche-Comté, CHRU de Besançon, 25030 Besançon, France; Unité extrapyramidale, département des neurosciences cliniques, HUG, faculté de médecine, université de Genève, 1205 Genève, Suisse.
Revue Neurologique
|September 19, 2018
Summary
Impulse control disorders (ICDs) are common in Parkinson's disease (PD) patients undergoing dopamine replacement therapy (DRT). Early detection and specific management strategies are crucial for improving quality of life.
Area of Science:
- Neurology
- Neuroscience
- Psychiatry
Background:
- Impulse control disorders (ICDs), punding, and dopamine dysregulation syndrome are frequent non-motor complications of dopamine replacement therapy (DRT) in Parkinson's disease (PD).
- These conditions significantly impair patients' quality of life.
- Their development stems from intricate interactions involving individual predispositions, non-physiological dopaminergic stimulation, and PD pathology.
Purpose of the Study:
- To review the nature of impulse control disorders and related behaviors in Parkinson's disease patients on DRT.
- To discuss the underlying mechanisms, including mesolimbic pathway sensitization.
- To outline current and complementary management strategies for this hyperdopaminergic behavioral spectrum.
Main Methods:
- Review of existing literature on non-motor complications of DRT in PD.
- Analysis of the role of dopaminergic stimulation in the development of ICDs.
- Discussion of management strategies including behavioral monitoring and medication adjustments.
Main Results:
- ICDs and related behaviors are underrecognized but significant complications of DRT in PD.
- Sensitization of the mesolimbic pathway is a key factor in the emergence of addictive behaviors.
- Management involves early behavioral detection, judicious use of dopamine agonists, and levodopa dosage fractionation.
Conclusions:
- Effective management of ICDs in PD requires a multi-faceted approach.
- Understanding the neurobiological underpinnings is essential for therapeutic development.
- Addressing these non-motor symptoms is critical for enhancing patient quality of life.